瞬时弹性成像受控衰减参数的预后价值
该研究纳入2012年8月至2016年3月期间接受瞬时弹性成像检查且肝脏硬度测量可靠、受控衰减参数测量≥10次的连续患者,评估受控衰减参数对肝脏相关事件、非肝细胞癌癌症及心血管事件的预测价值。结果显示受控衰减参数在单因素分析中不能预测上述结局,多因素分析中肝脏硬度、男性、血小板计数、血清白蛋白及乙型肝炎病因独立预测肝脏相关事件。
要点
- 受控衰减参数在单因素分析中不能预测肝脏相关事件、非肝细胞癌癌症或心血管事件。
- 肝脏硬度、男性、血小板计数、血清白蛋白及乙型肝炎病因独立预测肝脏相关事件。
- 年龄是非肝细胞癌癌症的唯一独立预测因素;年龄、空腹血糖、总胆固醇和肌酐预测心血管事件。
核心结论
- 瞬时弹性成像测定的受控衰减参数所反映的肝脂肪变存在与否及其严重程度均不能预测短期内的肝脏相关事件、癌症或心血管事件。
研究设计与样本
- 纳入2012年8月至2016年3月期间接受瞬时弹性成像检查、肝脏硬度测量可靠且受控衰减参数测量≥10次的连续患者,最终4,282例纳入分析(男性56.7%,中位年龄57岁)。
主要发现
- 在8,540患者年随访期间,发生肝脏相关事件45例(肝细胞癌34例、肝功能失代偿33例),新诊断非肝细胞癌癌症73例,心血管事件65例(急性冠脉综合征27例、脑血管意外25例、冠状动脉介入35例)。
- 单因素分析中受控衰减参数不能预测肝脏相关事件、非肝细胞癌癌症或心血管事件。
- 多因素分析中肝脏硬度、男性、血小板计数、血清白蛋白及乙型肝炎病因独立预测肝脏相关事件。
- 年龄是非肝细胞癌癌症的唯一独立预测因素;年龄、空腹血糖、总胆固醇和肌酐预测心血管事件。
- 病毒性肝炎和NAFLD患者的亚组分析结果相似。
关键数值与推荐
- 肝脏硬度中位数6.1 kPa,受控衰减参数中位数250 dB/m。
- 瞬时弹性成像检查指征:疑似非酒精性脂肪性肝病40.7%、乙型肝炎37.0%、丙型肝炎2.9%、其他19.4%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Liver stiffness measurement (LSM) by transient elastography (TE) has been shown to predict outcomes in patients with liver disease. While controlled attenuation parameter (CAP) measurement can accurately quantify hepatic steatosis, its prognostic value is unknown. We aim to determine if CAP is predictive for liver-related events (LRE), non-hepatocellular carcinoma (HCC) cancers, and cardiovascular events (CVE). METHODS: Consecutive patients with both a reliable LSM and ≥10 successful CAP measurements by TE from August 2012 to March 2016 were included in the analysis. LRE were defined as HCC or hepatic decompensation. CVE were defined as acute coronary syndrome (ACS), cerebrovascular accident (CVA), or coronary intervention (stenting or bypass). RESULTS: Of the 5,848 patients that were examined, 4,282 (56.7% male, median age 57 years) had adequate follow-up, reliable LSM (median 6.1 kPa), and ≥10 CAP measurements (median 250 dB/m). Indications for TE were: suspected non-alcoholic fatty liver disease (NAFLD) (40.7%), hepatitis B (HBV) (37.0%), hepatitis C (2.9%), and others (19.4%). During 8,540 patient-years of follow-up, there were 45 patients with LRE (34 HCC, 33 decompensations), 73 with newly diagnosed non-HCC cancers, and 65 with CVE (27 ACS, 25 CVA, and 35 coronary interventions). CAP did not predict LRE, non-HCC cancer, or CVE on univariate analysis. On multivariate analysis, LSM, male sex, platelet count, serum albumin, and HBV etiology independently predicted LRE; age was the only independent predictor of non-HCC cancer; while age, fasting blood glucose, total cholesterol, and creatinine predicted for CVE. Subgroup analyses of viral hepatitis and NAFLD patients revealed similar results. CONCLUSION: Neither the presence nor the severity of hepatic steatosis as measured by CAP predict LRE, cancer, or CVE in the short term.
引用
- Liu K, Wong VW, Lau K, et al. Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. Am J Gastroenterol. 2017. PMID: 29087391. doi:10.1038/ajg.2017.389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。